Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | 0.00% | +5.60% | +12.82% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.82% | 97.9M | |
+8.64% | 114B | |
+10.33% | 104B | |
-12.69% | 22.41B | |
-0.52% | 22.28B | |
-5.80% | 19.07B | |
-37.36% | 18B | |
-5.36% | 17.89B | |
+6.83% | 14.28B | |
+36.31% | 12.55B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Insider Trends: Insider Buying Prolonged with Purchase of Clearside Biomedical Shares